CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.10% for the 12-month period ending 2024-12-28, per its 10-K filed 2026-02-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.10%.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.60%.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -0.40%.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -0.80%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-28 | -0.10% 10-K · filed 2026-02-18 | |
| 2023-12-30 | -0.60% 10-K · filed 2026-02-18 | 0.10% 10-K · filed 2024-02-14 |
| 2022-12-31 | -0.40% 10-K · filed 2025-02-19 | |
| 2021-12-25 | -0.80% 10-K · filed 2024-02-14 | -0.70% 10-K · filed 2022-02-16 |
| 2020-12-26 | -1.40% 10-K · filed 2023-02-22 | -0.70% 10-K · filed 2021-02-17 |
| 2019-12-28 | 0.50% 10-K · filed 2022-02-16 | 0.80% 10-K · filed 2020-02-11 |
| 2018-12-29 | -1.00% 10-K · filed 2021-02-17 | 0.70% 10-K · filed 2019-02-13 |
| 2017-12-30 | 0.50% 10-K · filed 2020-02-11 | 1.80% 10-K · filed 2018-02-13 |
| 2016-12-31 | 4.00% 10-K · filed 2019-02-13 | |
| 2015-12-26 | 1.80% 10-K · filed 2018-02-13 | |
| 2014-12-27 | 2.50% 10-K · filed 2017-02-14 | 2.40% 10-K · filed 2015-02-17 |
| 2013-12-28 | 1.00% 10-K · filed 2016-02-12 | 0.60% 10-K · filed 2015-02-17 |
| 2012-12-29 | 1.50% 10-K · filed 2015-02-17 | 1.60% 10-K · filed 2013-02-27 |
| 2011-12-31 | 1.60% 10-K · filed 2014-02-25 | |
| 2010-12-25 | 1.00% 10-K · filed 2013-02-27 | |
| 2009-12-26 | 0.60% 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |